PLCB1 and type 2 diabetes mellitus: Based on the above, we suspected that upregulated PKG2 by cinaciguat could inhibit the activation of PLCβ1, relieve intracellular calcium overload, and then suppress ER stress to ameliorate osteoblast functions under T2DM condition.